美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

INVESCO BIOTECHNOLOGY & GENOME ETF

94.96

+1.591.70%

成交量：7,383

成交額：70.22萬

市值：4.12億

市盈率：52.95

高：95.42

開：94.85

低：94.77

收：93.37

52周最高：98.82

52周最低：67.69

股本：434.00萬

流通股本：434.00萬

量比：1.06

換手率：0.17%

股息：1.55

股息率：1.63%

每股收益(TTM):1.79

每股收益(LYR):18.65

淨資產收益率：24.76%

總資產收益率：0.08%

市淨率：1.67

市盈率(LYR):5.09

資料載入中...

總覽公司新聞資訊公告

美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾

老虎资讯综合

諾華試驗受挫且BMO下調評級，安進股價下跌

盤前異動：安進、耐克、Bloom Energy 等個股受關注

美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創

安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。

富國銀行上調安進目標價至435美元

諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

Stoke Therapeutics與渤健在第16屆歐洲癲癇大會上公布Zorevunersen長期臨床數據，力證Dravet綜合徵治療藥物的疾病修飾潛力

阿爾尼拉姆製藥公司(ALNY)股票9月2日盤中上漲7.90%：釋放什麼信號？

TradingKey中文

梯瓦製藥（TEVA）與Royalty Pharma（RPRX）合作抗體藥物TEV'408迎重大臨床突破

特瓦公司一款免疫系統疾病藥物在中期臨床試驗中達到了主要目標

安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可

高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯

高盛9月「確信名單」更新：美股納入福泰製藥歐股力推萊茵、Adyen和塔蘭克斯

美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極

英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者

英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor

衞材宣佈：加拿大藥品管理局最終推薦侖卡奈單抗（Leqembi）在早期阿爾茨海默病中獲得報銷資格

特朗普政府將宣佈藥品定價協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/PBE/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":94.955,"timestamp":1789665671385,"preClose":93.3693,"halted":0,"volume":7383,"delay":0,"changeRate":0.01698309829890556,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"交易中","change":1.5857,"latestTime":"09-17 13:28:44 EDT","open":94.85,"high":95.42,"low":94.765,"amount":702189.15636,"amplitude":0.007015,"askPrice":95.21,"askSize":400,"bidPrice":95,"bidSize":500,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.3693,"sharesOutstanding":3180000,"nav":93.02867,"aum":405605001.2,"dividendRate":0.016322,"bidAskSpread":0.001979,"preHourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":92.89213,"preClose":93.3693,"latestTime":"19:30 EDT","volume":12,"amount":1120.613,"timestamp":1789601405975,"change":-0.47717,"changeRate":-0.005111,"amplitude":0},"volumeRatio":1.06204,"impliedVol":0.1148,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.06204,"shares":4340000,"dividePrice":1.5499,"high":95.42,"amplitude":0.007015,"preClose":93.3693,"low":94.765,"week52Low":67.69,"pbRate":"1.67","psRate":"240.06","week52High":98.82,"institutionHeld":0.2552,"latestPrice":94.955,"committee":0.111111,"eps":1.793292,"divideRate":0.016322,"volume":7383,"delay":0,"ttmEps":1.793292,"open":94.85,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":93.03,"twentyDayClose":98.2643,"sixtyDayClose":85.4379},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103332998","title":"美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","LU0823417653.USD","LU0056508442.USD","LU0541501648.USD","LU1093756325.SGD","OZEM","BK4141","LU0976567544.SGD","LU1069347547.HKD","LU2505996509.AUD","IE0004086264.USD","LU1804176565.USD","IGV","LU0070217475.USD","LU1983299246.USD","LU1150488218.USD","CGDG","LU0950375773.USD","LU2129689431.USD","LU0359202008.SGD","LU0889566641.SGD","LU0124676726.USD","LU0278409577.USD","SG9999013999.USD","LU2125154935.USD","BK4548","LU2087621335.USD","SGXZ57979304.SGD","BK4599","LU0061474960.USD","IE00BLSP4452.SGD","LU0345774391.USD","IE00BHPRN162.USD","LU1718418525.SGD","BK4535","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","LU2129689514.USD","LU0868494617.USD","IE00B19Z3581.USD","EFA","BK4526","LU2089283258.USD","LU2362541513.USD","LU2543165471.USD","IE00BQXX3C00.GBP","TTEQ","FDTX","LU2458330243.SGD","LU2360108059.USD","LU0868494708.USD","BK4566","SG9999001440.SGD","LU2023250504.SGD","LU2506951958.HKD","AIQ","LU0878005551.USD","LU0289739699.SGD","LU1803068979.SGD","SG9999014575.USD","XLE","BK4201","DDM","LU0130103400.USD","LU0823434583.USD","LU1064131342.USD","BBH","LUMA","LU2491050154.USD","LU1366192091.USD","LU2764262908.HKD","LU0300736062.USD","LU1989772923.USD","LU1585245621.USD","LU1778281490.HKD","FTXL","LU1066053197.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU0823416689.USD","LU1282649067.USD","QQQA","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","LU1894683348.USD","LU2430703251.USD","LU0654597011.USD","LEGR","LU2264538146.SGD","LU0545039389.USD","LU0081259029.USD","WEEI","BK4503","LU1868838027.USD","LU1992135472.HKD","LU1935042488.USD","PPH","LU0572939691.SGD","LU0345770993.USD","LU1282649810.SGD","INTW","LU2362540622.SGD","SPTE","BK4570","LU0368265418.SGD","LU1023057109.AUD","LU2211814178.USD","LU0211327993.USD","LU0965509101.SGD","LU2237443549.SGD","LU0476273544.USD","LU0122379950.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","BK4528","IE00BQXX3F31.USD","LU1974910355.USD","BK5113","BK4007","PXI","IE00BFXG1179.USD","LU2063271972.USD","TRUN","AVEM","LU0238689110.USD","IE000SO60NU8.SGD","BK4097","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU0162691827.USD","LU2896262040.SGD","WQTM","LU0256863811.USD","LU0143863784.USD","LU2244417387.USD","LU0048573561.USD","SG9999000418.SGD","LU2487616109.SGD","LU0070302665.USD","LU1935043536.SGD","LU1046421795.USD","LU0957791311.USD","LU0251132253.USD","IE00BN8TJ469.HKD","IYE","EPAI","LU0345769631.USD","LU0444973449.USD","IXC","IE00BBT3K403.USD","LU1989764748.USD","LU2764263203.CNY","LU0466842654.USD","LU1267930227.SGD","LU0094547139.USD","CRAK","BK4534","BK4516","BLOX","BK4148",".DJI","LU2324357040.USD","LU1917777945.USD","ASIA","INT","LU1791710582.SGD","LU2505996681.GBP","LU0210528500.USD","IE00B7SZL793.SGD","QTUP","LU2473716301.USD","LU1861215975.USD","LU1435385759.SGD","LU2271345857.HKD","LU0738911758.USD","LU0882574055.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","LU0553294199.USD","BK4532","LU1815336760.USD","IE00B19Z4B17.USD","LU0742534661.SGD","LU2471134879.HKD","OILT","LU2089984988.USD","LU1582986359.USD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","ASMH","LU0496365809.HKD","BK4023","ERX","LU0274383776.USD","DBEF","LU2360106780.USD","LU1489326972.SGD","IE00BZ1G4Q59.USD","TDIV","IBBQ","IE00B5949003.HKD","LU0314106906.USD","LU0114720955.EUR","LU0143863198.USD","IE00BFXG0V08.USD","PQNT","LU0097036916.USD","LU0149725797.USD","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","ORCU","LU0109394709.USD","LU2491049909.HKD","LU0648000940.SGD","CGNG","LU0072461881.USD","LU0208291251.USD","LU0266512127.USD","BK4504","LU0321505439.SGD","LU0157215616.USD","LU0823038988.USD","LU1935043023.USD","RSPG","DRIV","LU0942090050.USD","LU1929549753.HKD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","IFLR","LU2360107168.USD","LU1935042215.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","LU0052756011.USD","LU0985489474.SGD","LU2720916845.USD","VDE","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU0084288322.USD","BIB","LU1150488135.SGD","SMH","CTEX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","BK4170","LU2430703178.SGD","LU2236285917.USD","LU0211328371.USD","LU2592432038.USD","LU1674673428.USD","LU2663582299.SGD","SPWO","HYDR","LU0541502299.USD","LU1674673691.USD","LU2111349929.HKD","LU2148611432.USD","IE00BD6J9T35.USD","LU0068578508.USD","LU2471134796.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU0138981039.USD","AVXC","CNAV","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2750360641.GBP","BK4157","LU1894683264.USD","FENI","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","LU0868486357.SGD","LU0823039010.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2506951875.HKD","OGIG","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2326559502.SGD","IE000BZT7R73.USD","TEK","LU1023059063.AUD","GNMX","LU0320765992.SGD","LU0058720904.USD","03165","LU1582987597.SGD","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","IE00B1XK9C88.USD","IE0002270589.USD","LU0128525689.USD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1989771016.USD","SG9999004220.SGD","SG9999002224.SGD","LU1720051017.SGD","IEO","LU1066051498.USD","LU0612318385.USD","LU0300736492.USD","SPY","LU2250418816.HKD","IE00B775SV38.USD","IE000WAW04H5.SGD","LU2028103732.USD","IE00BLSP4239.USD","LU1429558221.USD","LU0175139822.USD","LU0154245673.USD","LU0823421416.USD","LU0029874061.USD","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","LU2272731782.SGD","LU2087625088.SGD","GXPE","SGXZ81514606.USD","LU0289960550.SGD","LU0264606111.USD","BK7095","BK4533","LU0154236417.USD","LU0878004406.USD","LU1057294990.SGD","ILOW","LU2054465674.USD","LU2237443382.USD","BK4538","LU1201861165.SGD","IE0009356076.USD","IE0031619046.USD","IE000MB6IJN5.SGD","DOG","LU2746668461.USD","LU1506573853.SGD","LU2764263039.SGD","BK4121","ORCX","AIS","FENY","LU1074936037.SGD","IEFA","SG9999011175.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","DRLL","LU2602419157.SGD","BK4529","DIG","LU1989764664.SGD","IBB","HK0000304797.USD","LU0267386448.USD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU2471134523.USD","LU0321505868.SGD","BK4559","IE00B1BXHZ80.USD","IE00B2Q91V27.USD","LU2506952170.USD","IE0004445239.USD","LU0384037296.USD","THNR","LU0683600562.USD","LU2290526834.HKD","ORCL","LU1316542783.SGD","CQTM","LU0788109394.HKD","LU1548497426.USD","ORAC","BK4505","EGGY","LU1823568750.SGD","TINS","LU0433182093.SGD","DIA","WUGI","LU0488056044.USD","MEMX","DBEU","LU0234572021.USD","LU1720051108.HKD","FOTO","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LINT","AVSE","BK4213","BK4605","BGIA","TEXU","LU0965509283.SGD","LU0320765489.SGD","IE0004091025.USD","PBE","BK4591","LU0612318971.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU0211326755.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","BK4608","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","PXE","LU2322448957.HKD","LU0130517989.USD","BK4543","LU0256331488.USD","LU0353189763.USD","LU1868837722.USD","LU2462591277.SGD","LU0359201885.HKD","LU1691799644.USD","LU0310800965.SGD","FTXN","IE0000B7K699.USD","BK4527","LU1861220033.SGD","LU0320765646.SGD","SG9999015358.SGD","BK4588","NVS","INYY","LU0353189680.USD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","IGE","ORCS","SG9999001176.SGD","LU2237443978.SGD","IE00B3CCJ963.GBP","LU1582987324.SGD","LU1582986433.USD","LU0889565833.HKD","GNOM","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","TBXU","LU1430594728.SGD","LU1061106388.HKD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","SG9999003800.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU0431992006.USD","LU2294711713.HKD","LU0648001328.SGD","LU1048588211.SGD","LU2506952097.USD","SG9999001424.SGD","SDOW","LU0053666078.USD","BK4602","UDOW","LU0143551892.USD","LU0154245756.USD","CGIC","TNGY","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","LU0477156953.USD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU2362541273.HKD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","LU2242646821.SGD","BK4592","LU2272731600.USD","LU2242652126.USD","LU0122376428.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2237957902.USD","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","XNTK","LU0323591593.USD","LU2112291526.USD","LU0792757196.USD","LU2347655156.SGD","SG9999001176.USD","LU1992135399.USD","LU2133065610.SGD","SPRX","LU1430597077.USD","LU0203347892.USD","FFGX","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","INTC","LU1267930490.SGD","FCG","LU0661504455.SGD","LU1235294995.USD","LU2129689605.HKD","BK4612","LU0980610538.SGD","BK4082","LU1162221912.USD","BAI","LU0823421333.USD","LU1852331112.SGD","LU1623119135.USD","LU1734074674.USD","LU0949170772.SGD","LU0048584097.USD","IE00BGHQF524.EUR","LU0345774631.USD","LU0251142724.SGD","LU0266512473.USD","LU0823417737.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","LU0128526141.USD","GSID","BK4147","UMMA","BK4515","LU0823434740.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2249611893.SGD","LU0158827948.USD","BK7104","LU2458330169.SGD","LU1035773651.USD","IE00BSNM7G36.USD","BK4579","LU2357125470.USD","LU1988902786.USD","LU2089985449.USD","BK4139","KNOW","LU0444971666.USD","LU0211326839.USD","LU2298321311.HKD","LU2750360997.AUD","CORO","LU1839511570.USD","LU2237957811.SGD","LU2468319806.SGD","LU0528227936.USD","LU1291159041.SGD","LU0130102774.USD","LU0266013472.USD","LU0251131958.USD","BK4138","BK4585","CWI","LU0912757837.SGD","LU0310799852.SGD","LU0345780950.USD","LU0878866978.SGD","ORCZ","IE00B5TLWC47.USD","IE000F7OJYX1.SGD","IE00B66KJ199.SGD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級，安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级，安进股价下跌9月8日-** 安进公司（AMGN.O）股价盘前下跌4.8%，至416美元** 诺华公司（NOVN.S）的降胆固醇药物在一项备受关注的研究中未能达标，这引发了市场对安进公司（Amgen）实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示，诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期，而该","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0868494617.USD","LU0320765992.SGD","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595225","title":"盤前異動：安進、耐克、Bloom Energy 等個股受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595225?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858632,"startTime":"0","endTime":"0","summary":"安进：这家生物科技巨头、道琼斯指数的重要权重股，其盘前股价重挫逾5%。此前，瑞士制药商诺华宣称，其一款实验性药物在晚期临床试验中未能有效降低心血管风险。安进与礼来目前正在各自研发竞品疗法以应对挑战。消息传出后，诺华在欧股市场大跌10%，礼来股价亦小幅走低。Bloom Energy：这家燃料电池制造商可谓利好连连。受此提振，其盘前股价上扬4%。游戏驿站定于今日美股收盘后发布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07399","IE00BJT1NW94.SGD","MSTW","LU2098885051.SGD","CRPT","HOOX","BK4599","BK4532","PJP","BPAY","MSST","NVS","CONL","SMST","LU0823414478.USD","HOOZ","COII","ROBN","07799","FIAT","IE00BJJMRZ35.SGD","LU0708994859.HKD","LU2360107671.USD","LU0122379950.USD","MSTK","BBH","LU0058720904.USD","IMST","OWNB","LMI3.UK","BK4561","COIO","BK4533","EGGY","BK4596","LU1057294990.SGD","LU1303367103.USD","LU1861559042.SGD","BK4182","CONY","GMEC","CONX","HODU","LU1267930813.SGD","LU0957808578.USD","BK4127","FDIG","IBLC","07311","MSTZ","LU2249611893.SGD","LU1988902786.USD","LU0070302665.USD","09711","LU2089984988.USD","LU0052756011.USD","APED","BK4541","BK4539","BK4581","LU1861220207.SGD","BK4516","VTWG","MSTR","BK4600","LU0211331839.USD","ICLN","GMEY","IE0009355771.USD","LU0889566641.SGD","BK4146","COIG","CONI","LU0109394709.USD","LU0823414551.USD","LU0868494617.USD","LU2468319806.SGD","IGME","LU0476273544.USD","LU0208291251.USD","NKE","PPH","COYY","09399","LU0128525689.USD","LU0128525929.USD","3SMI.UK","BE","BK4566","LU0289739699.SGD","TBXU","BK4007","SIMS","04332","ICOI","LU1064131342.USD","UPGR","LU2264538146.SGD","LU1642822529.SGD","LU1267930227.SGD","HOOD","MSOO","BK4139","MSTY.UK","BK4558","BK4578","HOOI","BEZ","LU2357125470.USD","MSTP","ZAP","LU0029864427.USD","COIA","IE00BFTCPJ56.SGD","LU2506951792.HKD","SMI3.UK","MSTX","HOYY","LU2543165471.USD","LU1571399168.USD","BITQ","GME","MSDD","IE0009354923.USD","BK4588","HOOW","LU0310800379.SGD","IE00B2B36J28.USD","AMGN","IE0002141913.USD","HOOG","MTYY","BK4585","BK4112","BEX","IE00BFXG0V08.USD","MST","FINX","BLCK","IE00B4R5TH58.HKD","LU1267930573.SGD","LU0823411888.USD","DAPP","LU0889565916.HKD","LU1861558580.USD","BEG","07711","WNTR","BK4554","IE00BYQQ9H92.USD","09799","BK4534","COIN","BK4577","LU0444973449.USD","HOOY","MEDX","MSTU","COIX","CTEC","HOOC","IAI","BK4023","LU2112291526.USD","VCLN","BK4595","LU0320765992.SGD","BKCH","LU0320765489.SGD","LU1815336760.USD","LU1983299246.USD","BK4547","BK4076","LU1061106388.HKD","09311","BK4535","HOII","LU0786609619.USD","BEC","IBBQ","STYL","LU0792757196.USD","SG9999001440.SGD","COIW","IBAT","PBE","LU2294711713.HKD","GMEU","FRNW","LU1861217088.USD","BK4551","3LMI.UK","LU0310800965.SGD","MSTC","WATS","MSTY","CNRG","LU0444971666.USD","SMOG","MSII","LU2242646821.SGD","IBB","BIB","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765489.SGD","LU0320765992.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","PPH","IBBQ","LU2242652126.USD","BK4578","LU0211331839.USD","LU2112291526.USD","TBXU","BK4139","IBB","LU2089984988.USD","LU0208291251.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","MEDX","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4581","AMGN","BIB","IE00B4R5TH58.HKD","NVS","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK4534","LU1023059063.AUD","BK4533","BK4585","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665258833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","MDTX","PPH","LU0889565916.HKD","BBH","BK4534","LU0122379950.USD","BIB","LU0211331839.USD","BK4007","IBBJ","LU2089984988.USD","SG9999001440.SGD","BK4585","BK4533","BK4578","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","NVS","BMED","IE0002141913.USD","LU0320765489.SGD","LU0109394709.USD","LU2242646821.SGD","LU0070302665.USD","LU1061106388.HKD","IBB","LU0320765992.SGD","BK4532","BK4566","LU2242652126.USD","TBXU","LU2112291526.USD","LU1057294990.SGD","AMGN","LU0058720904.USD","PSYK","MEDX","BK4599","IE00BJJMRZ35.SGD","LU0289739699.SGD","PJP","BK4581","LU0868494617.USD","LU1983299246.USD","PBE","LU0208291251.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富國銀行上調安進目標價至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1023059063.AUD","BK4599","LU2242652126.USD","BK4582","IBB","AMGN","UUP","BK4533","LU2112291526.USD","LU2089984988.USD","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4534","BK4581","IE00BJJMRZ35.SGD","BK4139","LU0289739699.SGD","PGF","IE0009355771.USD","IE00B4R5TH58.HKD","IBBQ","PBE","LU2242646821.SGD","IE0002141913.USD","LU1571399168.USD","BIB","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","LU1061106388.HKD","PJP","IE00B2B36J28.USD","UDN","BK4566","BBH","LU0122379950.USD","LU0868494617.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","LLY","LLII","JDOC","FHLC","CANC","PJP","IBB","LU2324357040.USD","IYH","NAMS","PPH","CURE","ELIL","LU0456855351.SGD","GDOC","TMED","IE00BK4W5L77.USD","LU1988902786.USD","VHT","PBE","FTXH","LU2491049909.HKD","BIB","IHE","ELIS","LLYZ","TBXU","ILDR","SLN","AGNG","LU1551013425.SGD","LU2746668974.SGD","AMGN","THNR","LU0096364046.USD","IBBQ","BBH","BK4588","MHIP","XLV","MEDX","MEDI","TRUH","WDNA","BK4581","RXL","OZEM","HRTS","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU1057294990.SGD","IBBQ","BK4533","LU2242652126.USD","IE0009355771.USD","BK4007","LU2468319806.SGD","LU0320765992.SGD","NVS","BK4581","LU0070302665.USD","BK4139","LU0211331839.USD","PPH","IE00B2B36J28.USD","MEDX","BK4532","IE00BJT1NW94.SGD","LU2089984988.USD","IE0002141913.USD","LU2112291526.USD","BK4534","LU1571399168.USD","IBB","BK4599","BK4566","IE00BJJMRZ35.SGD","BBH","LU1061106388.HKD","BK4578","LU1023059063.AUD","SG9999001440.SGD","BIB","PBE","AMGN","LU0868494617.USD","IE00B4R5TH58.HKD","BK4588","LU0208291251.USD","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","LU0320765489.SGD","LU0122379950.USD","PJP","LU2242646821.SGD","LU0889565916.HKD","LU0289739699.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194645441","title":"Stoke Therapeutics與渤健在第16屆歐洲癲癇大會上公布Zorevunersen長期臨床數據，力證Dravet綜合徵治療藥物的疾病修飾潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194645441","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194645441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 07:31","pubTimestamp":1788478271,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics与渤健公司于第16届欧洲癫痫大会上联合呈现了Zorevunersen的长期临床数据，这些数据有力支持了这款用于治疗Dravet综合征的在研药物所具备的疾病修饰潜力。Zorevunersen作为一种实验性疗法，其最新公布的长期随访结果备受业界关注。此次大会上披露的数据，进一步印证了该药物在改变Dravet综合征疾病进程方面的可能性，为这一罕见且严重的癫痫性脑病治疗领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z9P08.USD","BK4585","IE00B894F039.SGD","BIIB","BK4139","LU0889565916.HKD","BK4533","PBE","BK4532","IE00B19Z9Z06.USD","LU0234570918.USD","BK4588","LU0320765992.SGD","STOK","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664143843","title":"阿爾尼拉姆製藥公司(ALNY)股票9月2日盤中上漲7.90%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664143843","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664143843?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 00:16","pubTimestamp":1788365792,"startTime":"0","endTime":"0","summary":"• 受到积极临床数据及华尔街分析师正面看好的提振，Alnylam股价大幅上涨。\n• Amvuttra在治疗心肌病方面展现出卓越疗效和强劲的临床试验结果。\n• 该公司报告年收入为37.1亿美元，技术指标呈中性。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262146919-market-movers-alny-20260902","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0889565916.HKD","BK4548","LU0109394709.USD","GNMX","LU0320765992.SGD","BK4585","ALNY","LU0114720955.EUR","LU0882574055.USD","PBE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333811","title":"梯瓦製藥（TEVA）與Royalty Pharma（RPRX）合作抗體藥物TEV'408迎重大臨床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333811","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664333811?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:07","pubTimestamp":1788350836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 梯瓦制药 与Royalty Pharma宣布，双方合作开发的抗白细胞介素-15抗体药物TEV'408在治疗成人乳糜泻的2a期临床试验中取得积极结果。在给药第8周时，与安慰剂组相比，TEV'408在统计学上显著且临床上有效地预防了由麸质诱发的肠道损伤。根据“乳糜泻症状日记”显示，接受TEV'408治疗的患者其胃肠道症状评分明显低于安慰剂组。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4559","BK4584","LU1983299246.USD","LU2324357040.USD","IHE","PBE","TEVA","RPRX","BK4557","BK4585","BK4566","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081923","title":"特瓦公司一款免疫系統疾病藥物在中期臨床試驗中達到了主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081923?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:02","pubTimestamp":1788350525,"startTime":"0","endTime":"0","summary":"特瓦公司一款免疫系统疾病药物在中期临床试验中达到了主要目标路透9月2日-以色列制药商梯瓦制药工业公司周三表示，其一款试验性药物有助于预防成人乳糜泻患者因麸质引发的肠道损伤，达到了中期临床试验的主要目标。乳糜泻是一种自身免疫性疾病，其中麸质会引发免疫反应，从而损伤小肠。TEV-408目前还正在针对白癜风进行测试，并计划针对该皮肤病启动另一项中期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4T44U120:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4585","LU1983299246.USD","TEVA","IHE","BK4559","BK4588","PBE","RPRX","LU2324357040.USD","BK4557","BK4596","BK4007","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664194548?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BIB","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","PJP","IPOS","IE0009355771.USD","BK4533","AMGN","LU0320765992.SGD","BK4581","PBE","TBXU","LU1983299246.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","BK4139","AZNH","LU2242652126.USD","LU2112291526.USD","LU0122379950.USD","LU1061106388.HKD","LU2468319806.SGD","LU0868494617.USD","BK4599","BK4534","IBBQ","LU1057294990.SGD","BK4566","BBH","BK4585","LU0289739699.SGD","LU1571399168.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNMX","IDNA","IE0002141913.USD","LU0289739699.SGD","BK4585","LU2237438978.USD","LU0061475181.USD","TBXU","LU0096364046.USD","BBH","LU2237443549.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","BIB","LU1791807156.HKD","LU2456880835.USD","IE00BZ9MQY76.HKD","LU0868494708.USD","BK4127","LU0868494617.USD","LU1668664300.SGD","LU0251131958.USD","SG9999001176.SGD","IE0009355771.USD","IEV","LU2468319806.SGD","IBBQ","LU1674673691.USD","LU2471134523.USD","LU2462157665.USD","BK4533","BK4550","LU2471134952.CNY","VRTX","LU1868837300.USD","IBB","VXUS","LU0432979614.USD","IE00B19Z9P08.USD","LU1868836914.USD","IE00B19Z9Z06.USD","VGK","GSX","PBE","BK4588","LU0942090050.USD","SG9999001176.USD","LU2237443978.SGD","LU1144417596.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月「確信名單」更新：美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443549.SGD","BIB","SG9999001176.USD","LU2236285917.USD","GSX","IE0034235188.USD","SG9999001176.SGD","VRTX","LU0345770993.USD","LU2471134796.USD","MSFU","IBB","LU2471134523.USD","BK4533","VGK","BBH","MSFO","MSFX","GNMX","LU0106831901.USD","XYZY","WFC","LU2362541273.HKD","IE00BJT1NW94.SGD","IE0002270589.USD","EL","VXUS","MSFC","IDNA","LU2471134952.CNY","IE00B2B36J28.USD","CRNX","LU2417539215.USD","IBKR","LU1868836757.USD","UNHU","UNH","IE00BFXG1179.USD","LU2468319806.SGD","IE0004091025.USD","UNHW","LU1585245621.USD","TBXU","UN","LU2471134879.HKD","XYZ","DAL","BK4532","IE00B19Z3581.USD","IEV","XYZG","MSFT","BK4504","LU0432979614.USD","LU2750360641.GBP","BK4585","LU0889565916.HKD","COP","MSFW","MSFL","UNHG","PBE","LU0109394709.USD","LU1868837300.USD","LU1868837136.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","IBBQ","LU1069344957.HKD","MSFY","LU2456880835.USD","MSFD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GNOM","PBE","BBH","BK4007","MRNY","IEHS","MRNX","PJP","FBT","RSPH","IBRN","IE0009355771.USD","SYNB","IDNA","MEDI","IBB","BIOY","TMED","FTXH","IEIH","LU0211331839.USD","LU2473716301.USD","IE00BFTCPJ56.SGD","HELX","IE00BJJMRZ35.SGD","SBIO","PSCH","BME","LU2272731600.USD","LFSC","BBP","LU2322448957.HKD","PBPH","PPH","IYH","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","CANC","BK4585","RXL","WDNA","XBIX","AZNH","BIB","LU0070302665.USD","NVS","MEDX","XPH","BK4588","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","BK7511","AMGN","BK4585","IBBQ","BIB","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","BK7501","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","CSL.AU","BK7067","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","BK7508","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局（MHRA）已正式告知上市许可持有方，关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节，意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110244724","title":"衞材宣佈：加拿大藥品管理局最終推薦侖卡奈單抗（Leqembi）在早期阿爾茨海默病中獲得報銷資格","url":"https://stock-news.laohu8.com/highlight/detail?id=1110244724","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110244724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:08","pubTimestamp":1788199690,"startTime":"0","endTime":"0","summary":"卫材今日宣布，加拿大药品管理局已就仑卡奈单抗在早期阿尔茨海默病治疗中的报销事宜发布最终积极推荐。这一决定意味着，符合条件的加拿大患者将有望获得这一创新疗法的公共资金支持。加拿大药品管理局经过严谨的临床证据评估后，最终给出了肯定意见。卫材公司表示，将继续与加拿大各省及地区的卫生部门密切协作，推动报销政策的实际落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BMED","BK4532","BIIB","IE00B894F039.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0109394709.USD","LU0234570918.USD","BK4139","LU0320765992.SGD","BK4533","BK4588","LU0889565916.HKD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普  预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU1623119135.USD","LU2265009873.SGD","LU2089283258.USD","LU2168564149.EUR","SG9999014880.SGD","OZEM","BK4581","IE00B19Z3581.USD","LU0882574139.USD","PPH","LU1868837300.USD","IXJ","XLV","LU0432979614.USD","SG9999002224.SGD","BK7067","ILDR","LU0385154629.USD","LU1066051498.USD","BK4566","LU2596442595.SGD","IE00B2B36J28.USD","IE00BJLML261.HKD","IE0002270589.USD","LU0820561909.HKD","LU0316494557.USD","LU0320765992.SGD","LU1093756168.USD","LU2089984988.USD","LU0889565916.HKD","IE0009355771.USD","CSL.AU","IE00B7KXQ091.USD","LU0689472784.USD","LU2168564495.EUR","LU0158827781.USD","LU1868836914.USD","BK7501","LU1366192091.USD","LU0106261372.USD","LU2491050154.USD","SG9999014906.USD","LU0823416689.USD","LU2361045086.USD","LU1023059063.AUD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU1868836591.USD","SG9999001440.SGD","LLII","LU0198837287.USD","SG9999018857.SGD","LU2602419157.SGD","LU0323591593.USD","LU2023251221.USD","SG9999001176.SGD","LU1894683348.USD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU1057294990.SGD","BK4568","IE00BJJMRX11.SGD","SG9999018865.SGD","IYH","LU1267930730.SGD","ELIS","LU0345770308.USD","LU0985481810.HKD","IE00BFSS8Q28.SGD","BK7511","LU0158827948.USD","LU0306806265.USD","LU0882574055.USD","LU0238689110.USD","LU1323610961.USD","LU1868837136.USD","LU2471134879.HKD","LU2756315664.SGD","SG9999013999.USD","LU1035775433.USD","LU1712237335.SGD","LU2213496289.HKD","LU2361044949.HKD","LU0203201768.USD","IBBQ","LU2471134523.USD","LU2471134796.USD","LU2456880835.USD","LU0417517546.SGD","LU2237443978.SGD","LLYX","IE0004445239.USD","LU2087625088.SGD","LU0210536198.USD","LU2461242641.AUD","BK4534","IE00BLSP4239.USD","LU1127390331.HKD","IE00B19Z3B42.SGD","GDOC","LU0466842654.USD","LU0868494617.USD","JDOC","LU0256863902.USD","LU1093756325.SGD","IHE","LU2552382215.SGD","LU2237443465.HKD","LU0320765059.SGD","LU1979441026.SGD","LU1069344957.HKD","LU1548497426.USD","BK4139","LU2108987350.USD","LU2462591350.SGD","AMGN","IE00B4R5TH58.HKD","TMED","LU1061106388.HKD","LU0109394709.USD","LU2264538146.SGD","LU2417539215.USD","SGXZ57979304.SGD","BK4007","LU0006306889.USD","LU2111349929.HKD","BBH","LU2237443895.HKD","PBE","LU1720051108.HKD","04332","IE00BFTCPJ56.SGD","IE00B1XK9C88.USD","IE000M9KFDE8.USD","LU2237443382.USD","LU2168564065.EUR","PJP","LU2491050071.SGD","LU2211815571.USD","BK4516","LU1291159041.SGD","SG9999015978.USD","BK4533","LU2357305700.SGD","SGXZ81514606.USD","LU2552382132.HKD","BK7508","LU2324357040.USD","LU0345770993.USD","LLY","IBB","LU2361044865.SGD","LU1629891620.HKD","LU1983299246.USD","LU2746668974.SGD","LU2236285917.USD","LU0672654240.SGD","SGXZ51526630.SGD","THNR","IE00BKDWB100.SGD","IE00B3T34201.USD","IE00BBT3K403.USD","LU0225284248.USD","LU2756315318.SGD","LU0306807586.USD","BK4592","LU0094547139.USD","HRTS","LU0096364046.USD","SGXZ99366536.SGD","LU0353189680.USD","BK4588","LU2471134952.CNY","FHLC","LU0708995401.HKD","LU1974910355.USD","LU1804176565.USD","LU2242646821.SGD","LU2271345857.HKD","SG9999011175.SGD","LU0321505868.SGD","SG9999001176.USD","WDNA","LU2028103732.USD","LU1989771016.USD","MEDI","MEDX","BK4550","LU0943347566.SGD","LU2168563687.JPY","SG9999015945.SGD","LU0225283273.USD","LU2896262040.SGD","IE0004445015.USD","LU0354030438.USD","LU0122379950.USD","LU0471298694.HKD","LU2023250504.SGD","GB00BDT5M118.USD","LU0353189763.USD","MHIP","LU0109391861.USD","LU0823434583.USD","LU0133085943.USD","SGXZ31699556.SGD","SG9999003800.SGD","IE00BFSS7M15.SGD","IE00BN29S564.USD","IONS","LU0174119429.USD","LU0456855351.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU0061475181.USD","LU0234572021.USD","LU2237443549.SGD","LU2168564222.USD","LU0640476718.USD","BK4599","LU2237438978.USD","LU2468319806.SGD","ELIL","LU0079474960.USD","LU1064131342.USD","LU2106854487.HKD","LLYZ","IE00BK4W5L77.USD","LU0354030511.USD","LU0823434740.USD","IE00B775H168.HKD","LU0683600562.USD","CURE","IE00BJJMRZ35.SGD","LU0225771236.USD","LU1883839398.USD","CANC","FTXH","PFE","LU0787776722.HKD","LU0170899867.USD","LU0203202063.USD","BIB","LU1814569148.SGD","LU0114720955.EUR","RXL","IE00B4JS1V06.HKD","LU0097036916.USD","LU2462157665.USD","SG9999014914.USD","LU1571399168.USD","VHT","LU1232071149.USD","LU1720051017.SGD","LU2750360997.AUD","SG9999014898.SGD","LU0964807845.USD","TRUH","LU1894683264.USD","IE0001KFT4U8.USD","LU1988902786.USD","LU2746668461.USD","LU1917777945.USD","LU0321505439.SGD","LU1066053197.SGD","LU2237443622.USD","LU1145028129.USD","LU2112291526.USD","LU0820562030.AUD","LU2491049909.HKD","LU0256863811.USD","SG9999002232.USD","LU0786609619.USD","SG9999015952.SGD","LU0471298777.SGD","LU1868836757.USD","SG9999015986.USD","LU2552382058.USD","LU0058720904.USD","IE00BK4W5M84.HKD","LU2242652126.USD","TBXU","LU2023250330.USD","LU0289739699.SGD","LU0266013472.USD","LU1551013425.SGD","LU0820561818.USD","LU2089284900.SGD","AGNG","BK4585","LU2750360641.GBP","IE0002141913.USD","LU1551013342.USD","LU2360106947.USD","SG9999017495.SGD","LU2063271972.USD","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":152,"code":"91000000","status":"200"}]}}